[Muscle & hepatic glycogen changes induced by hypoglycemic sulfonamides appear to be due to stimulation of endogenous insulin secretion].
D006003:Glycogen / Q000378:metabolism*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000502:physiology*; D008099:Liver / Q000378:metabolism*; D008112:Liver Glycogen; D009132:Muscles / Q000378:metabolism*; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides
D007004:Hypoglycemic Agents; D007328:Insulin; D008112:Liver Glycogen; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D006003:Glycogen
ANTIDIABETICS/effects; GLYCOGEN/metabolism; INSULIN/physiology; LIVER/metabolism; MUSCLES/metabolism
Les modifications du glycogène hépatique et musculaire produites par les sulfamides hypoglycémiants paraissent dues à la stimulation de la sécretion d'insuline endogène.